<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-10T16:44:39+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-TZA-C-MDH-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>To reduce HIV infections by 85%, new HIV infections among children by less than 4%, AIDS related deaths by 80%; and HIV related stigma to 5%, all from 2010 baseline by 2025. - Tanzania (United Republic) (01-Jan-2024-30-Jun-2025)</narrative>
    </title>
    <description type="1">
      <narrative>Tanzania (United Republic), TB/HIV, Management and Development for Health (MDH)</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To reduce new HIV infections  by 85% in 2025 from the 2010 baseline (110,000); To reduce Mother to Child Transmission by the end of breastfeeding to ≤4% by 2025; To reduce AIDS related deaths by 80% in 2025 from the 2010 baseline (64,000); To reduce HIV related stigma to &lt;5% by 2025 from 2013 baseline of 28% for external stigma and 20.5% for internal stigma; To reduce burden and suffering from Tuberculosis and Leprosy diseases in Tanzania by 2025. Objectives: To implement efficient testing strategies so that 95% of people living with HIV will know their status by 2026; To reduce HIV related stigma to less than 5% by 2025 from 2013 baseline of 25% for external stigma and 20.5% for internal stigma; To reduce the percentage of mother to child transmission at the end of breast feeding period, from an estimated 7.9% (in 2021), to &lt;4% by the end of 2025/6; To increase TB treatment coverage from 53percent in 2018 to 90percent by innovatively addressing barriers to access, utilization, and the needs of the key and vulnerable populations for TB care and prevention services; To strengthen TB services to the population of miners and their families by 2025.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Management and Development for Health (MDH)</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Management and Development for Health (MDH)</narrative>
    </participating-org>
    <other-identifier ref="TZA-C-MDHP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2025-06-30" />
    <activity-date type="4" iso-date="2025-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Sarah Asiimwe</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>sarah.asiimwe@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="TZ" percentage="100">
      <narrative>Tanzania (United Republic)</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="54.75">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="28.66">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="16.59">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="891c6028-9f9a-427f-8e25-55b502d52054" percentage="0.59">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing outside of KP and AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="0.48">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.48">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="fa74be82-0e67-471f-99cd-c36d38ba6843" percentage="0.92">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Early infant diagnosis and follow-up HIV testing for exposed infants</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="4.43">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="9d329dd4-6e6b-430c-80f6-afb56fbbbacd" percentage="1.16">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Condom and lubricant programming for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="f9b562f4-a21f-4bc7-b20c-8ff6fa8aa1a6" percentage="0.36">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Condom and lubricant programming for male sexual partners of AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="0a745960-07a1-46b7-add6-90d0e9ec5fd4" percentage="11.63">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; HIV prevention communication, information and demand creation for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="e71b58f8-6d5d-4f73-93c5-cea93aefb0c3" percentage="1.23">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="6fcd5647-f3de-44bd-8c27-be59771546a9" percentage="9.79">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Social protection interventions for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="92423e34-c66c-47f4-9cac-58b9e0ea01fc" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.74">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="5.39">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="b7a2ebc7-33dc-42f2-b664-e760a5d99b0a" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Removing human rights-related barriers to prevention for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="cfd9f41e-52ee-4b8f-a55c-e416fa546878" percentage="0.83">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Community empowerment for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="52020c8d-d3b6-42f6-9137-038784523b8a" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Condom and lubricant programming for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="f8c4da37-2413-429d-8c58-e36e539aafc7" percentage="0.4">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Pre-exposure prophylaxis (PrEP) programming for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="d01264fd-1485-4b1a-b85c-fbaa2fa20933" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="09268318-342f-41af-84e1-0aab4e2fd8f3" percentage="0.23">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Community empowerment for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="12d964e1-5c4b-4caa-9b00-225bb89861dd" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Community empowerment for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="10.06">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="10e03ea0-16be-40e1-9fba-682edec921d0" percentage="0.97">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="3.64">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="423a40f4-4716-48a1-9c6c-7b78ede223af" percentage="0.26">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="22.65">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="1.89">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="2.81">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="1.19">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="0.12">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="1.85">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="2.78">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="1.67">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="0ed16776-d36f-4d43-a8fc-294a23927ba7" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Community mobilization and advocacy, including support to TB survivor-led groups</narrative>
        </description>
      </budget-item>
      <budget-item code="24043b35-97d4-4fe5-ba14-64ab665ff4f2" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Reducing TB-related gender discrimination, harmful gender norms and violence</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="9.6">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.5">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">14879674.00</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">13927605.11</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">12202173.97</value>
    </budget>
    <capital-spend percentage="5.46" />
    <transaction ref="dcd758de-e566-4c73-9503-5815bf5192a8">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-19" />
      <value currency="USD" value-date="2024-01-19">21843476.51</value>
      <description>
        <narrative>Global Fund commitment to TZA-C-MDHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6bfc7f38-94a9-4a54-a476-d8f52f9bc8af">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-30" />
      <value currency="USD" value-date="2024-01-30">3258148.28</value>
      <description>
        <narrative>Global Fund disbursement to TZA-C-MDHP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="22f7d580-acf9-4afd-bcad-fd546a51805f">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-05" />
      <value currency="USD" value-date="2025-09-05">0.00</value>
      <description>
        <narrative>Global Fund commitment to TZA-C-MDHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c8ea9325-49f4-4f05-90f3-68637034b6c0">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-05" />
      <value currency="USD" value-date="2025-09-05">-18585328.23</value>
      <description>
        <narrative>Global Fund commitment to TZA-C-MDHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a1a37d51-3e65-4d88-848b-5f9bf06c02a5">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">2561321.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from TZA-C-MDHP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3698c618-80b6-416b-a453-453e4a3b63c9">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-21" />
      <value currency="USD" value-date="2025-11-21">-2561321.00</value>
      <description>
        <narrative>Global Fund commitment to TZA-C-MDHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9e335ab5-254b-4bfe-9973-56b9093a715d">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-02" />
      <value currency="USD" value-date="2026-03-02">1221.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from TZA-C-MDHP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="691f1f5e-ad10-436a-a9a7-b0e14c68c2e1">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-06" />
      <value currency="USD" value-date="2026-03-06">-1221.00</value>
      <description>
        <narrative>Global Fund commitment to TZA-C-MDHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="TZA-C-MDHP01-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">640724.00</value>
      <description>
        <narrative>Expenditure reported by Management and Development for Health (MDH) for TZA-C-MDHP01, Jan 2024 to Jun 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </provider-org>
    </transaction>
    <transaction ref="TZA-C-MDHP01-EXP-20250731">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-07-31" />
      <value currency="USD" value-date="2025-07-31">55909.00</value>
      <description>
        <narrative>Expenditure reported by Management and Development for Health (MDH) for TZA-C-MDHP01, Jul 2025 to Jul 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Management and Development for Health (MDH)</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/TZA-C-MDH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/TZA/2023/TB_HIV/en/TZA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 2 - TB/HIV - Tanzania (United Republic) - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1550-TZA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-05-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
      </title>
      <description>
        <narrative>Module: Collaboration with other providers and sectors.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="70.9">
          <comment>
            <narrative>Numerator: 3094; Denominator: 4364.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="75">
            <comment>
              <narrative>Numerator: 1636.5; Denominator: 2182.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="84.97">
            <comment>
              <narrative>Numerator: 1854; Denominator: 2182.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="83">
            <comment>
              <narrative>Numerator: 2018.56; Denominator: 2432.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="19.18">
          <comment>
            <narrative>Numerator: 5298; Denominator: 27621.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6763.44; Denominator: 7514.93.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9393.66; Denominator: 10437.4.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 13151.12; Denominator: 14612.36.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of at-risk AGYW that have received an HIV test during the reporting period in AGYW programs</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of at-risk AGYW that have received an HIV test during the reporting period in AGYW programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="22.83">
          <comment>
            <narrative>Numerator: 57304; Denominator: 251001.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="21.82">
            <comment>
              <narrative>Numerator: 83912.11; Denominator: 384477.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="36.38">
            <comment>
              <narrative>Numerator: 139853.51; Denominator: 384477.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="53.59">
            <comment>
              <narrative>Numerator: 206050.84; Denominator: 384477.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="86.96">
          <comment>
            <narrative>Numerator: 27743; Denominator: 31902.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="14.4">
            <comment>
              <narrative>Numerator: 25021.01; Denominator: 173757.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="28.8">
            <comment>
              <narrative>Numerator: 50042.02; Denominator: 173757.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="43.2">
            <comment>
              <narrative>Numerator: 75063.02; Denominator: 173757.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women who know their HIV status</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women who know their HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="98.04">
          <comment>
            <narrative>Numerator: 186418; Denominator: 190146.36.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 93209; Denominator: 186418.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 93209; Denominator: 186418.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 94141; Denominator: 188282.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="959" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="959" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1055" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="1266" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="37.8">
          <comment>
            <narrative>Numerator: 251001; Denominator: 664108.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="30">
            <comment>
              <narrative>Numerator: 115343.1; Denominator: 384477.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 192238.5; Denominator: 384477.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="65">
            <comment>
              <narrative>Numerator: 249910.05; Denominator: 384477.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="106" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="1616" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="2016" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="4422" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="21.35">
          <comment>
            <narrative>Numerator: 5898; Denominator: 27621.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="18">
            <comment>
              <narrative>Numerator: 9393.66; Denominator: 52187.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="25">
            <comment>
              <narrative>Numerator: 13046.75; Denominator: 52187.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="35">
            <comment>
              <narrative>Numerator: 18265.45; Denominator: 52187.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="2678" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="5197" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="7592" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="10989" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="82.56">
          <comment>
            <narrative>Numerator: 31902; Denominator: 38643.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="20">
            <comment>
              <narrative>Numerator: 34751.4; Denominator: 173757.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="40">
            <comment>
              <narrative>Numerator: 69502.8; Denominator: 173757.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 104254.2; Denominator: 173757.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="17605" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="18485" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="18926" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="19366" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>